Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ERNAW

Ernexa Therapeutics Inc.

CIK 0000748592 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.06
↑ 0.00 (8.25%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$92.07K
P/E Ratio
-0.01
EPS
-2.24
Dividend Yield
Not covered
52W Position
17%
Beta
2.44

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.03
P/S
Not covered
EV/Revenue
Not covered
ROE
-383.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

136 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 17%
$0.02$0.23

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$14.08M
Total Assets
$5.83M
Free Cash Flow
-$7.05M

Recent news